Parkman Healthcare Partners LLC - Q2 2022 holdings

$272 Million is the total value of Parkman Healthcare Partners LLC's 76 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 37.5% .

 Value Shares↓ Weighting
UTHR BuyUNITED THERAPEUTICS CORP DEL$21,633,000
+62.7%
91,806
+23.9%
7.97%
+104.8%
UNH BuyUNITEDHEALTH GROUP INC$14,798,000
+14.6%
28,811
+13.8%
5.45%
+44.2%
SGEN SellSEAGEN INC$13,558,000
+9.3%
76,626
-11.0%
4.99%
+37.5%
DHR BuyDANAHER CORPORATION$9,752,000
-10.1%
38,466
+4.0%
3.59%
+13.1%
XENE SellXENON PHARMACEUTICALS INC$8,960,000
-3.6%
294,559
-3.2%
3.30%
+21.3%
WAT NewWATERS CORP$8,688,00026,250
+100.0%
3.20%
IQV SellIQVIA HLDGS INC$8,615,000
-25.6%
39,701
-20.7%
3.17%
-6.4%
ANTM NewELEVANCE HEALTH INC$8,566,00017,750
+100.0%
3.16%
NBIX BuyNEUROCRINE BIOSCIENCES INC$8,343,000
+40.7%
85,589
+35.4%
3.07%
+77.1%
IRTC SellIRHYTHM TECHNOLOGIES INC$7,994,000
-51.2%
74,001
-28.8%
2.94%
-38.6%
CTLT SellCATALENT INC$7,255,000
-17.2%
67,618
-14.5%
2.67%
+4.1%
CDMO BuyAVID BIOSERVICES INC$7,038,000
-15.2%
461,226
+13.2%
2.59%
+6.7%
ALT BuyALTIMMUNE INC$6,549,000
+247.4%
559,755
+80.8%
2.41%
+337.0%
LEGN SellLEGEND BIOTECH CORPsponsored ads$6,479,000
+48.0%
117,807
-2.2%
2.39%
+86.3%
IONS NewIONIS PHARMACEUTICALS INC$6,453,000174,300
+100.0%
2.38%
CTIC BuyCTI BIOPHARMA CORP$6,275,000
+497.1%
1,051,047
+367.1%
2.31%
+650.3%
AVTR BuyAVANTOR INC$5,358,000
+0.0%
172,269
+8.8%
1.97%
+25.9%
CVS SellCVS HEALTH CORP$4,962,000
-42.7%
53,547
-37.5%
1.83%
-28.0%
THC SellTENET HEALTHCARE CORP$4,846,000
-59.5%
92,190
-33.8%
1.78%
-49.0%
NewR1 RCM INC$4,829,000230,413
+100.0%
1.78%
CNCE BuyCONCERT PHARMACEUTICALS INC$4,732,000
+272.0%
1,124,072
+197.8%
1.74%
+368.5%
RCUS BuyARCUS BIOSCIENCES INC$4,339,000
-17.8%
171,214
+2.3%
1.60%
+3.4%
ACRS SellACLARIS THERAPEUTICS INC$4,256,000
-63.0%
304,843
-54.4%
1.57%
-53.5%
ATEC BuyALPHATEC HLDGS INC$3,425,000
-34.1%
523,735
+15.9%
1.26%
-17.1%
COO SellCOOPER COS INC$3,288,000
-59.8%
10,500
-46.4%
1.21%
-49.4%
SDGR BuySCHRODINGER INC$3,228,000
-18.4%
122,225
+5.5%
1.19%
+2.8%
ANIP BuyANI PHARMACEUTICALS INC$3,221,000
+6.2%
108,559
+0.6%
1.19%
+33.6%
NewARCELLX INC$3,218,000178,000
+100.0%
1.18%
NewPROCEPT BIOROBOTICS CORP$3,089,00094,500
+100.0%
1.14%
MASS Sell908 DEVICES INC$3,074,000
-7.6%
149,315
-14.7%
1.13%
+16.2%
PODD BuyINSULET CORP$3,027,000
-10.3%
13,889
+9.6%
1.12%
+12.9%
ALNY SellALNYLAM PHARMACEUTICALS INC$3,024,000
-65.7%
20,734
-61.6%
1.11%
-56.8%
MNKD BuyMANNKIND CORP$2,914,000
+17.3%
764,814
+13.2%
1.07%
+47.6%
PFMT BuyPERFORMANT FINL CORP$2,660,000
-10.6%
1,011,324
+5.7%
0.98%
+12.5%
NTRA SellNATERA INC$2,624,000
-50.4%
74,047
-43.0%
0.97%
-37.6%
COGT NewCOGENT BIOSCIENCES INC$2,605,000288,750
+100.0%
0.96%
DXCM BuyDEXCOM INC$2,596,000
-60.2%
34,834
+173.5%
0.96%
-49.9%
SUPN SellSUPERNUS PHARMACEUTICALS INC$2,564,000
-27.2%
88,658
-18.6%
0.94%
-8.3%
APEN SellAPOLLO ENDOSURGERY INC$2,373,000
-51.6%
650,000
-19.8%
0.87%
-39.1%
AKYA BuyAKOYA BIOSCIENCES INC$2,374,000
+43.7%
184,785
+22.9%
0.87%
+81.0%
IMUX SellIMMUNIC INC$2,256,000
-81.7%
650,028
-40.3%
0.83%
-76.9%
CDXS SellCODEXIS INC$2,134,000
-61.4%
204,049
-23.9%
0.79%
-51.4%
DAWN NewDAY ONE BIOPHARMACEUTICALS I$2,054,000114,750
+100.0%
0.76%
BuyIMAGO BIOSCIENCES INC$1,974,000
-26.7%
147,387
+5.5%
0.73%
-7.7%
KRMD BuyREPRO MED SYS INC$1,709,000
-11.1%
675,434
+0.4%
0.63%
+11.7%
HAE NewHAEMONETICS CORP MASS$1,630,00025,000
+100.0%
0.60%
NewRXSIGHT INC$1,619,000115,000
+100.0%
0.60%
AXGN BuyAXOGEN INC$1,544,000
+50.8%
188,494
+46.2%
0.57%
+89.7%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$1,527,000
-23.1%
21,336
+5.5%
0.56%
-3.3%
VCYT BuyVERACYTE INC$1,472,000
-12.0%
73,966
+22.0%
0.54%
+10.8%
LNTH SellLANTHEUS HLDGS INC$1,415,000
+1.1%
21,427
-15.3%
0.52%
+27.4%
KROS SellKEROS THERAPEUTICS INC$1,320,000
-66.6%
47,788
-34.3%
0.49%
-58.0%
FULC BuyFULCRUM THERAPEUTICS INC$1,287,000
-66.9%
262,689
+59.7%
0.47%
-58.3%
HBIO SellHARVARD BIOSCIENCE INC$1,266,000
-67.8%
351,750
-44.5%
0.47%
-59.5%
LNDC BuyLANDEC CORP$1,213,000
-9.1%
121,618
+5.5%
0.45%
+14.3%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$1,208,000
+2.8%
124,708
+5.5%
0.44%
+29.4%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$1,014,000
-59.7%
60,426
+5.5%
0.37%
-49.3%
TKNO BuyALPHA TEKNOVA INC$1,008,000
-38.9%
119,997
+0.4%
0.37%
-23.2%
STRO SellSUTRO BIOPHARMA INC$961,000
-41.5%
184,518
-7.7%
0.35%
-26.4%
HCAT SellHEALTH CATALYST INC$914,000
-56.1%
63,104
-20.9%
0.34%
-44.8%
OPNT BuyOPIANT PHARMACEUTICALS INC$907,000
+30.1%
75,632
+132.3%
0.33%
+63.7%
PSTV BuyPLUS THERAPEUTICS INC$828,000
-45.7%
1,533,075
+0.4%
0.30%
-31.8%
TELA BuyTELA BIO INC$764,000
-39.5%
108,984
+0.4%
0.28%
-23.8%
ZYME BuyZYMEWORKS INC$667,000
-14.6%
125,806
+5.5%
0.25%
+7.4%
TVTX NewTRAVERE THERAPEUTICS INC$636,00026,250
+100.0%
0.23%
MIRM BuyMIRUM PHARMACEUTICALS INC$623,000
-6.7%
32,014
+5.5%
0.23%
+17.4%
PHAT BuyPHATHOM PHARMACEUTICALS INC$583,000
-34.6%
69,135
+5.5%
0.22%
-17.6%
FMTX SellFORMA THERAPEUTICS HLDGS INC$542,000
-53.1%
78,603
-36.8%
0.20%
-40.8%
ALLK BuyALLAKOS INC$502,000
-42.1%
160,376
+5.5%
0.18%
-27.2%
LXRX NewLEXICON PHARMACEUTICALS INC$465,000250,000
+100.0%
0.17%
RCKT BuyROCKET PHARMACEUTICALS INC$367,000
-8.5%
26,677
+5.5%
0.14%
+15.4%
BLRX BuyBIOLINERX LTDsponsored ads$365,000
-21.2%
285,454
+5.5%
0.13%
-1.5%
SIEN SellSIENTRA INC$351,000
-70.3%
419,176
-21.2%
0.13%
-62.7%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$332,000
-20.0%
52,733
+5.5%
0.12%
+0.8%
SLN NewSILENCE THERAPEUTICS PLCads$311,00026,250
+100.0%
0.12%
SURF SellSURFACE ONCOLOGY INC$190,000
-69.1%
115,577
-44.7%
0.07%
-61.1%
VSTM ExitVERASTEM INC$0-190,755
-100.0%
-0.08%
NRIX ExitNURIX THERAPEUTICS INC$0-20,663
-100.0%
-0.08%
MTEM ExitMOLECULAR TEMPLATES INC$0-103,709
-100.0%
-0.10%
ANAB ExitANAPTYSBIO INC$0-37,285
-100.0%
-0.27%
REPH ExitSOCIETAL CDMO INC$0-671,817
-100.0%
-0.35%
MRTX ExitMIRATI THERAPEUTICS INC$0-15,236
-100.0%
-0.37%
ATRC ExitATRICURE INC$0-25,236
-100.0%
-0.48%
GOSS ExitGOSSAMER BIO INC$0-200,185
-100.0%
-0.51%
MRVI ExitMARAVAI LIFESCIENCES HLDGS I$0-77,389
-100.0%
-0.80%
CRL ExitCHARLES RIV LABS INTL INC$0-10,000
-100.0%
-0.83%
OM ExitOUTSET MED INC$0-81,601
-100.0%
-1.08%
TFX ExitTELEFLEX INCORPORATED$0-12,500
-100.0%
-1.30%
SRRA ExitSIERRA ONCOLOGY INC$0-151,915
-100.0%
-1.42%
IDXX ExitIDEXX LABS INC$0-9,388
-100.0%
-1.50%
ABBV ExitABBVIE INC$0-45,731
-100.0%
-2.17%
BCRX ExitBIOCRYST PHARMACEUTICALS INC$0-476,978
-100.0%
-2.27%
RCM ExitR1 RCM INC$0-342,923
-100.0%
-2.69%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC16Q3 20236.3%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
XENON PHARMACEUTICALS INC16Q3 20233.3%
NATERA INC16Q3 20233.4%
AVID BIOSERVICES INC15Q3 20232.9%
SCHRODINGER INC15Q3 20234.2%
REPRO MED SYS INC15Q2 20232.0%
MANNKIND CORP15Q3 20231.6%
IQVIA HLDGS INC14Q1 20234.6%
INSULET CORP14Q3 20232.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings